Flutic/salmeterol 113/14mcg Inh(60)

Manufacturer TEVA PHARMACEUTICALS USA Active Ingredient Fluticasone and Salmeterol Inhalation Powder(floo TIK a sone & sal ME te role) Pronunciation floo TIK a sone & sal ME te role
It is used to treat asthma.Some brands are used to treat COPD (chronic obstructive pulmonary disease).It may be given to you for other reasons. Talk with the doctor.Do not use this drug to treat intense flare-ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
🏷️
Drug Class
Bronchodilator/Corticosteroid Combination
🧬
Pharmacologic Class
Long-acting beta2-adrenergic agonist (LABA) / Inhaled corticosteroid (ICS)
🀰
Pregnancy Category
C
βœ…
FDA Approved
Aug 2000
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

This medicine is a combination inhaler that contains two different types of medications: a corticosteroid (fluticasone) and a long-acting bronchodilator (salmeterol). The corticosteroid helps reduce inflammation in your lungs, making it easier to breathe. The bronchodilator helps relax the muscles around your airways, opening them up for easier breathing. It's used regularly, usually twice a day, to prevent asthma attacks or manage COPD symptoms. It is NOT for sudden breathing problems.
πŸ“‹

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for inhalation only. Continue using it as directed by your doctor or healthcare provider, even if you feel well. Take your dose at the same time every day.

After each use, rinse your mouth with water, but do not swallow the water. Instead, spit it out. If you are using multiple inhaled medications, ask your doctor which one to use first.

Preparing and Taking Your Dose

Only prepare a dose when you are ready to take it. If you prepare a dose and then close the inhaler without taking it, the medication will be wasted and the inhaler may be damaged. When taking your dose, do not breathe out into the inhaler. Close the inhaler after use.

Important Safety Precautions

Do not take an extra dose, even if you did not taste or feel the powder. Do not disassemble the device or wash it, and do not use it with a spacer. Also, avoid breathing out into the device.

Cleaning and Maintenance

To clean the mouthpiece, gently wipe it with a dry tissue or cloth. Do not wash it or submerge it in water.

Tracking Your Doses

The inhaler has a built-in dose counter to help you keep track of how many doses are left. Once the counter reaches "0," or after 1 month from opening the foil pouch, or when the expiration date is reached (whichever comes first), discard the inhaler.

Storage and Disposal

Store the medication at room temperature in a dry place, away from the bathroom. Keep it in the foil pouch until you are ready to use it.

What to Do If You Miss a Dose

If you miss a dose, skip it and return to your regular schedule. Do not take two doses at the same time or take extra doses.
πŸ’‘

Lifestyle & Tips

  • Use this medicine regularly, even if you feel well, to get the most benefit.
  • Do not use this inhaler for sudden breathing problems; always carry a separate rescue inhaler (e.g., albuterol) for acute symptoms.
  • Rinse your mouth with water and spit it out after each dose to help prevent oral thrush (a fungal infection in the mouth).
  • Do not swallow the water after rinsing.
  • Do not stop using this medicine suddenly without talking to your doctor, especially if you have been on it for a long time.
  • Avoid triggers that worsen your asthma or COPD (e.g., smoke, allergens, pollution).
  • Maintain good hydration and nutrition.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 1 inhalation (113/14 mcg) twice daily, approximately 12 hours apart
Dose Range: 113 - 250 mg

Condition-Specific Dosing:

asthma: 1 inhalation (113/14 mcg) twice daily
COPD: 1 inhalation (250/50 mcg) twice daily (Note: 113/14 mcg is not the standard COPD dose, but may be used in some cases)
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for this specific strength (lower strengths available for children 4-11 years)
Adolescent: For asthma, 1 inhalation (113/14 mcg) twice daily for adolescents β‰₯12 years of age
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment necessary
Moderate: No dosage adjustment necessary
Severe: No dosage adjustment necessary
Dialysis: No specific recommendations; systemic exposure is low

Hepatic Impairment:

Mild: No specific dosage adjustment necessary
Moderate: Use with caution; monitor for increased systemic corticosteroid effects
Severe: Use with caution; monitor for increased systemic corticosteroid effects

Pharmacology

πŸ”¬

Mechanism of Action

Fluticasone propionate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. It acts by binding to glucocorticoid receptors, inhibiting the release of inflammatory mediators (e.g., histamine, eicosanoids, leukotrienes) and suppressing the migration of inflammatory cells (e.g., eosinophils, mast cells, lymphocytes). Salmeterol xinafoate is a long-acting beta2-adrenergic agonist (LABA). It selectively binds to beta2-adrenergic receptors in the bronchial smooth muscle, leading to activation of adenyl cyclase, increased intracellular cyclic AMP (cAMP) levels, and subsequent relaxation of bronchial smooth muscle, resulting in bronchodilation.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Fluticasone: ~1% (oral), ~30% (inhaled); Salmeterol: Low systemic absorption from inhaled dose
Tmax: Fluticasone: 0.5-1 hour; Salmeterol: 5-10 minutes
FoodEffect: Not applicable for inhaled powder

Distribution:

Vd: Fluticasone: ~300 L; Salmeterol: ~16 L/kg
ProteinBinding: Fluticasone: ~91%; Salmeterol: ~96%
CnssPenetration: Limited

Elimination:

HalfLife: Fluticasone: ~8 hours (terminal); Salmeterol: ~5.5 hours (terminal)
Clearance: Fluticasone: ~1093 mL/min; Salmeterol: ~1200 mL/min
ExcretionRoute: Fluticasone: Feces (primarily), urine (minor); Salmeterol: Feces (~60%), urine (~25%)
Unchanged: Fluticasone: <5% (urine); Salmeterol: <5% (urine)
⏱️

Pharmacodynamics

OnsetOfAction: Salmeterol: 10-20 minutes
PeakEffect: Salmeterol: 2-4 hours
DurationOfAction: Salmeterol: 12 hours; Fluticasone: Sustained anti-inflammatory effect over 12 hours

Safety & Warnings

⚠️

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as salmeterol, increase the risk of asthma-related death. Data from a large, randomized, placebo-controlled clinical trial in asthma (SMART study) showed an increase in asthma-related deaths in patients receiving salmeterol. This finding with salmeterol is considered a class effect of LABAs. Therefore, fluticasone propionate and salmeterol inhalation powder is not indicated for the primary treatment of status asthmaticus or other acute episodes of asthma or COPD where intensive measures are required. Fluticasone propionate and salmeterol inhalation powder should not be initiated in patients during rapidly deteriorating or potentially life-threatening episodes of asthma or COPD. Fluticasone propionate and salmeterol inhalation powder should not be used to relieve acute symptoms; an inhaled, short-acting beta2-agonist (SABA) should be used to relieve acute symptoms. When initiating fluticasone propionate and salmeterol inhalation powder, patients who have been taking oral corticosteroids should be weaned cautiously from systemic corticosteroids. Fluticasone propionate and salmeterol inhalation powder should not be used more often than recommended, at higher doses than recommended, or with other LABA-containing products.
⚠️

Side Effects

Serious Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, difficulty breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal
Signs of high blood sugar: confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath
Signs of low potassium levels: muscle pain or weakness, muscle cramps, or an irregular heartbeat
Signs of a weak adrenal gland: severe nausea or vomiting, severe dizziness or fainting, muscle weakness, extreme fatigue, mood changes, decreased appetite, or weight loss
Signs of high or low blood pressure: severe headache or dizziness, fainting, or changes in vision
Chest pain or pressure
Rapid or abnormal heartbeat
Shakiness
Feeling nervous or agitated
Changes in behavior
Vision changes, eye pain, or severe eye irritation
Burning, numbness, or tingling sensations
Choking
Voice changes
Seizures
Bone pain
Sleep disturbances
Feeling extremely tired or weak
Vaginal itching or discharge
Weight gain
Mouth irritation or mouth sores
Redness or white patches in the mouth or throat

Respiratory Problems: A Life-Threatening Condition

This medication can cause severe breathing problems, which may be life-threatening. If you experience difficulty breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek medical help immediately.

Other Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild ones. If you notice any of the following side effects or any other symptoms that bother you or don't go away, contact your doctor:

Headache
Upset stomach or vomiting
Throat irritation
* Signs of a common cold

Reporting Side Effects

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening asthma or COPD symptoms (e.g., increased shortness of breath, wheezing, cough, need for rescue inhaler)
  • Signs of oral thrush (white patches in mouth or throat, soreness)
  • Hoarseness or voice changes
  • Tremor, nervousness, or fast heartbeat
  • Muscle cramps
  • Blurred vision or eye pain (rare, but can indicate glaucoma/cataracts)
  • Signs of infection (e.g., fever, chills, increased mucus, change in mucus color)
  • Allergic reaction (rash, hives, swelling of face/lips/tongue, severe difficulty breathing)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you are currently using a similar medication. If you are unsure, consult your doctor or pharmacist for clarification.
Any prescription or over-the-counter (OTC) medications, natural products, or vitamins you are taking that may interact with this medication. Certain medications used to treat conditions like HIV, infections, or depression may be contraindicated with this drug. Your doctor or pharmacist can advise you on potential interactions.
If you have a milk allergy.

Please note that this is not an exhaustive list of all potential interactions or health problems that may affect the use of this medication. To ensure your safety, it is crucial to:

Inform your doctor and pharmacist about all medications (prescription or OTC), natural products, and vitamins you are taking, as well as any health problems you have.
Verify that it is safe to take this medication with your existing medications and health conditions.
* Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

Important Warnings and Cautions

When taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are using this drug.

Effectiveness and Monitoring
It may take approximately 1 week to experience the full effects of this medication. If you have diabetes (high blood sugar), consult with your doctor, as this drug may increase blood sugar levels. Immediately contact your doctor if your breathing problems worsen, your rescue inhaler becomes less effective, or you need to use it more frequently.

Dosage and Administration
Do not exceed the prescribed dose or use this medication more often than directed. Overdose can be fatal, so it is crucial to follow your doctor's instructions. If you have any concerns, discuss them with your doctor.

Transitioning from Oral Steroids
When switching from an oral steroid to another form of steroid, you may be at risk for severe and potentially life-threatening side effects. Be aware of symptoms such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar. If you experience any of these symptoms, contact your doctor immediately.

Stressful Situations
In the event of a severe injury, surgery, or infection, you may require additional doses of oral steroids to help your body cope with the stress. Carry a warning card indicating that you may need extra steroids in such situations.

Long-term Use
Prolonged use of this medication may increase the risk of developing cataracts or glaucoma. Consult with your doctor and undergo regular eye exams as recommended.

Bone Health
Long-term use may also lead to weak bones (osteoporosis). Discuss your risk factors with your doctor and undergo bone density tests as advised.

Infection Risk
You may be more susceptible to infections while taking this medication. To minimize the risk, wash your hands frequently and avoid close contact with people who have infections, colds, or flu.

Viral Infections
If you have not had chickenpox or measles before, avoid exposure to these viruses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed, consult with your doctor.

Age-Related Considerations
If you are 65 or older, use this medication with caution, as you may be more prone to side effects.

Pediatric Considerations
In some cases, this medication may affect growth in children and teenagers. Regular growth checks may be necessary, so consult with your doctor.

Pregnancy and Breastfeeding
If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks of this medication with your doctor.

COPD Considerations
If you have chronic obstructive pulmonary disease (COPD), you are at a higher risk of developing pneumonia. This medication may further increase this risk, so consult with your doctor to discuss the potential risks and benefits.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Chest pain
  • Fast or irregular heartbeat (palpitations)
  • Tremor
  • Nervousness
  • Headache
  • Dizziness
  • Nausea
  • Vomiting
  • Muscle cramps
  • Dry mouth
  • Weakness
  • Seizures (rare)
  • Hypokalemia (low potassium)
  • Hyperglycemia (high blood sugar)
  • Adrenal suppression (with chronic overdose)

What to Do:

Seek immediate medical attention or call Poison Control at 1-800-222-1222. Treatment is supportive and symptomatic. Monitor cardiac function (ECG), serum potassium, and blood glucose. Consider judicious use of a cardioselective beta-blocker for severe cardiac symptoms, but only with extreme caution due to potential for bronchospasm.

Drug Interactions

🚫

Contraindicated Interactions

  • Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, cobicistat-containing products)
πŸ”΄

Major Interactions

  • Other long-acting beta2-adrenergic agonists (LABAs)
  • Non-selective beta-blockers (e.g., propranolol, carvedilol)
  • Diuretics (non-potassium sparing, e.g., thiazides, loop diuretics) - risk of hypokalemia
  • Tricyclic antidepressants (TCAs) and Monoamine oxidase inhibitors (MAOIs) - risk of cardiovascular effects
🟑

Moderate Interactions

  • Moderate CYP3A4 inhibitors (e.g., erythromycin, diltiazem, verapamil, grapefruit juice)
  • Sympathomimetics (additive effects)
  • Xanthine derivatives (e.g., theophylline) - increased risk of arrhythmias
🟒

Minor Interactions

  • Not typically listed as clinically significant for this drug

Monitoring

πŸ”¬

Baseline Monitoring

Pulmonary Function Tests (FEV1)

Rationale: To establish baseline lung function and assess disease severity.

Timing: Prior to initiation of therapy

Adrenal Function (e.g., morning cortisol)

Rationale: Consider if switching from systemic corticosteroids or if adrenal suppression is suspected.

Timing: Prior to initiation, if indicated

Ophthalmic Exam

Rationale: To screen for cataracts or glaucoma, especially in patients with risk factors or long-term use.

Timing: Prior to initiation, if indicated

πŸ“Š

Routine Monitoring

Pulmonary Function Tests (FEV1)

Frequency: Periodically (e.g., every 6-12 months or as clinically indicated)

Target: Improvement or maintenance of baseline function

Action Threshold: Worsening FEV1 or lack of improvement may indicate inadequate control or need for re-evaluation

Growth (Pediatric Patients)

Frequency: Regularly (e.g., every 3-6 months)

Target: Normal growth velocity

Action Threshold: Growth deceleration may indicate systemic corticosteroid effects

Oral Cavity Inspection

Frequency: At each clinical visit

Target: Absence of oral candidiasis

Action Threshold: Presence of thrush requires antifungal treatment and proper rinsing technique reinforcement

Signs/Symptoms of Adrenal Suppression

Frequency: Periodically, especially with high doses or prolonged use

Target: Absence of fatigue, weakness, nausea, vomiting, hypotension

Action Threshold: Presence of symptoms warrants investigation and potential dose adjustment or systemic steroid support

Ophthalmic Exam

Frequency: Annually for long-term users or those with risk factors

Target: Absence of cataracts or glaucoma progression

Action Threshold: Development or progression requires ophthalmology referral

Serum Potassium (if on diuretics)

Frequency: Periodically, as clinically indicated

Target: 3.5-5.0 mEq/L

Action Threshold: Hypokalemia requires intervention

πŸ‘οΈ

Symptom Monitoring

  • Asthma/COPD symptom control (e.g., frequency of shortness of breath, wheezing, cough, nocturnal awakenings)
  • Frequency of rescue inhaler use
  • Signs of oral candidiasis (white patches in mouth/throat)
  • Hoarseness or dysphonia
  • Tremor or palpitations
  • Muscle cramps
  • Blurred vision or eye pain
  • Signs of infection (e.g., fever, increased sputum)

Special Patient Groups

🀰

Pregnancy

Category C. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Asthma control is important during pregnancy, as uncontrolled asthma poses risks to both mother and fetus.

Trimester-Specific Risks:

First Trimester: Potential for teratogenicity, but human data are limited and generally reassuring for inhaled corticosteroids and LABAs.
Second Trimester: Generally considered safer than first trimester for drug exposure, but continued monitoring of asthma control is key.
Third Trimester: No specific risks identified, but monitor for potential effects on labor (beta-agonists can inhibit uterine contractions) and neonatal adrenal function (rarely, with high doses of ICS).
🀱

Lactation

It is not known whether fluticasone propionate or salmeterol are excreted in human breast milk. However, other corticosteroids and beta2-agonists are excreted. Caution should be exercised when administered to a nursing woman. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for the drug and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition.

Infant Risk: Low systemic absorption suggests low infant exposure. Monitor for signs of systemic corticosteroid effects (e.g., growth suppression) or beta-agonist effects (e.g., irritability, tremor, poor feeding) in the infant, though these are unlikely with typical inhaled doses.
πŸ‘Ά

Pediatric Use

Safety and effectiveness of fluticasone propionate and salmeterol inhalation powder 113/14 mcg have not been established in pediatric patients younger than 12 years of age. Growth velocity should be monitored in pediatric patients receiving inhaled corticosteroids, as they may cause a reduction in growth velocity. The lowest effective dose should be used.

πŸ‘΄

Geriatric Use

No dosage adjustment is generally required. However, elderly patients may be more susceptible to the cardiovascular effects of beta2-agonists (e.g., tremor, palpitations, increased blood pressure) and may have comorbidities (e.g., cardiovascular disease, diabetes, glaucoma, cataracts) that require careful monitoring.

Clinical Information

πŸ’Ž

Clinical Pearls

  • This medication is a controller medication and should be used consistently, not for acute relief of symptoms. Patients must have a separate rescue inhaler.
  • Proper inhalation technique is crucial for efficacy. Patients should be instructed on how to use the Diskus device correctly and to rinse their mouth after each dose.
  • Patients should be advised not to exceed the prescribed dose or frequency, as this increases the risk of adverse effects without additional benefit.
  • Monitor for signs of adrenal suppression, especially when transitioning from oral corticosteroids or with prolonged high-dose use.
  • Be aware of potential drug interactions, particularly with strong CYP3A4 inhibitors, which can significantly increase systemic exposure to both components.
  • For asthma, this combination is indicated for patients not adequately controlled on an inhaled corticosteroid alone or whose disease severity warrants initiation of both an ICS and a LABA.
πŸ”„

Alternative Therapies

  • Inhaled corticosteroids (e.g., fluticasone propionate, budesonide, mometasone)
  • Long-acting beta2-adrenergic agonists (e.g., salmeterol, formoterol, indacaterol, olodaterol) - *Note: LABAs should not be used as monotherapy for asthma.*
  • Long-acting muscarinic antagonists (LAMAs) (e.g., tiotropium, umeclidinium) - primarily for COPD, sometimes add-on for asthma
  • Leukotriene receptor antagonists (e.g., montelukast)
  • Oral corticosteroids (for severe exacerbations or refractory disease)
  • Biologic therapies (e.g., omalizumab, mepolizumab, dupilumab) for severe asthma
πŸ’°

Cost & Coverage

Average Cost: $300 - $600 per 60-dose inhaler
Generic Available: Yes
Insurance Coverage: Tier 2 or 3 (Brand), Tier 1 or 2 (Generic)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about your medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it happened.